Medtronic Announces Quarterly Cash Dividend of $0.71 Per Share for Q2 FY 2026

Medtronic has announced a cash dividend of $0.71 per ordinary share for the second quarter of fiscal year 2026. This is consistent with the dividend increase announced in May 2025. The dividend is payable on October 17, 2025, to shareholders of record at the close of business on September 26, 2025.

Medtronic plc (NYSE: MDT) has announced a cash dividend of $0.71 per ordinary share for the second quarter of fiscal year 2026. This dividend is consistent with the dividend increase announced in May 2025 and is payable on October 17, 2025, to shareholders of record at the close of business on September 26, 2025.

Medtronic, headquartered in Galway, Ireland, is a leading global healthcare technology company that has consistently increased its annual dividend payment for the past 48 consecutive years. This dividend increase underscores the company's commitment to rewarding shareholders and its strong financial health.

Despite recent challenges, including a 33% decline in stock value since mid-2021, Medtronic remains committed to improving its overall profitability and innovation. The company plans to spin off its diabetes business next year, which is expected to be accretive to earnings and free up capital for research and development or potential acquisitions.

Investors should note that Medtronic's business and stock performance may not improve overnight. The company is working on new product launches and addressing the challenges of regulatory approval and product development. However, the dividend yield currently stands at around 3.1%, historically high for the stock and well above the S&P 500 index's 1.2% yield.

References:
[1] https://www.aol.com/3-things-know-buy-medtronic-100000838.html
[2] https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-second-quarter-of-fiscal-year-2026-302530564.html